Schultes Birgit C
CIK 0002051419
EVP, Chief Scientific Officer
Filings
4
Latest Mar 3, 2026
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +0.4% | +0.4% | +32.7% | -31.9% |
| 90 days | 2 | 50% | +4.9% | +4.9% | +51.7% | -41.9% |
| 180 days | 1 | 100% | +37.9% | +37.9% | +37.9% | +37.9% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Schultes Birgit C has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 4 | Mar 3, 2026 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|